Rwanda triaged 136 cancer interventions to decide which ones actually needed a new cost-effectiveness model. https://www.mattheneus.com/editorial/adaptive-health-technology-assessment-decision-risk-chart-benefits-package-2026-10-01 #HTA #HealthEconomics #RWE

A Brazilian expert panel split equity and acceptability into two separate evidence jobs.
https://www.mattheneus.com/editorial/brazil-hta-equity-acceptability-delphi-consensus-evidence-strategy-2026-09-30
#HTA #EvidenceSynthesis #HealthEconomics

SMC accepts perioperative pembrolizumab in head and neck cancer; the multistate extrapolation carries the uncertainty. https://www.mattheneus.com/editorial/smc-pembrolizumab-keytruda-resectable-head-neck-acceptance-multistate-extrapolation-2026-09-07 #HTA #HealthEconomics

What a health technology assessment system looks like before it has local utilities or a willingness-to-pay threshold: Jordan.
https://www.mattheneus.com/editorial/jordan-health-technology-assessment-barriers-local-utilities-willingness-to-pay-threshold-2026-09-30
#HTA #HealthEconomics

TLV has added subcutaneous Phesgo to Sweden's benefits scheme for early and metastatic HER2+ breast cancer, leaning on APHINITY and CLEOPATRA. https://www.mattheneus.com/editorial/tlv-phesgo-subcutaneous-her2-breast-cancer-benefits-inclusion-aphinity-cleopatra-2026-09-30 #HTA #HealthEconomics

Sweden's TLV extends Kerendia (finerenone) reimbursement to heart failure with LVEF 40% or higher, broadening access beyond CKD. https://www.mattheneus.com/editorial/tlv-kerendia-finerenone-heart-failure-lvef-40-reimbursement-extension-2026-09-28 #HTA #HealthEconomics

Trajectories or transition probabilities? The engine choice decides what a therapy-sequence ICER can represent. https://www.mattheneus.com/editorial/ehr-microsimulation-trajectory-multistate-therapy-sequence-cost-effectiveness-2026-09-30 #HTA #HealthEconomics #RWE

Metabologia wants your research papers on the #metabolic aspects of #diabetes, #obesity, #CVD and #renal and #hepatic disease #comorbidity #nutrition #exercise #psychosocial #healtheconomics #healthtechnology – submit now! metabologia.org #EASD2026

Germany's G-BA approves secondary use of cervical screening data for a participation study — a notable step for real-world data access policy. #HTA #RWE #HealthEconomics https://www.mattheneus.com/editorial/g-ba-cervical-screening-secondary-data-use-approval-participation-2026-09-24

Australia's reimbursement committee flags three cancer trials where overall survival data moved after listing. https://www.mattheneus.com/editorial/pbac-overall-survival-monitoring-system-cancer-medicines-red-alert-trials-2026-09-29 #HTA #RWE #HealthEconomics

Queensland DCEA: diabetes screening yields 8562 QALYs of inequality reduction; the leading treatment, 514. https://www.mattheneus.com/editorial/queensland-inequality-impact-calculator-aggregate-distributional-cost-effectiveness-2026-09-29 #HTA #HealthEconomics

Allan Wailoo.

Please join us in giving Beth a massive congratulations on her new role, and celebrating Mark as he transitions into his research focus! 👏

#HealthEconomics #HealthPolicy #LeadershipTransition #EEPRU #EconomicEvaluation #ResearchImpact #AcademicLeadership

EU proposes a Council Recommendation on cardiovascular health checks, putting screening yield and budget impact on the evidence agenda. https://www.mattheneus.com/editorial/european-commission-cardiovascular-health-checks-council-recommendation-2026-09-28 #HTA #HealthEconomics

Submit to #Metabologia! One of EASD official journals and open to research papers on the #metabolic aspects of #diabetes, #obesity, #CVD and #renal and #hepatic disease #comorbidity #nutrition #exercise #psychosocial #healtheconomics #healthtechnology

Australia's first COCOON carer value set ranks financial burden above physical health, reshaping carer QoL in economic evaluation. https://www.mattheneus.com/editorial/cocoon-carer-value-set-australia-financial-burden-economic-evaluation-2026-09-29 #HTA #HealthEconomics

📢 Call for papers: Special Issue on The Health Economics of Artificial Intelligence in Medicine
📒 Journal: Pharmacoeconomics and Policy
📅 Submission deadline: 30 June 2027
🔗 Check more: https://ow.ly/jQrc50ZRZg2
#HealthEconomics #ArtificialIntelligence #Medicine

Lara Zibners and Adam Brown write that schools that do not integrate menopause training into their curricula are failing students, patients and society.

healthcaretoday.com/article/comm...

#Menopause #WomensHealth #MedicalEducation #HealthEconomics #HRT

Poland's AOTMiT opens a seven-day tariff consultation on robotic and laparoscopic radical prostatectomy. https://www.mattheneus.com/editorial/aotmit-robotic-surgery-laparoscopic-prostatectomy-device-cost-tariff-consultation-2026-09-28 #HTA #HealthEconomics #RegulatoryAffairs

BHEN #healtheconomics

Poland's AOTMiT refuses reimbursement for oral edaravone imported for amyotrophic lateral sclerosis. https://www.mattheneus.com/editorial/aotmit-radicut-edaravone-oral-suspension-als-targeted-import-non-recommendation-2026-09-28 #HTA #RegulatoryAffairs #HealthEconomics